Recombinant Influenza Vaccines (riv) - Vaccines

Relevant Publications

Protection against influenza hospitalizations from enhanced influenza vaccines among older adults: A systematic review and network meta-analysis.

Issue Release: 2024

Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2024-2025.

Issue Release: 2024

Comparison of immunogenicity of adjuvanted and high dose influenza vaccination in long-term care facility residents.

Issue Release: 2024

Trivalent and quadrivalent seasonal influenza vaccine in adults aged 60 and older: a systematic review and network meta-analysis.

Issue Release: 2024

Antibody response to sequential vaccination with cell culture, recombinant, or egg-based influenza vaccines among U.S. adults.

Issue Release: 2024

Relative Effectiveness and Immunogenicity of Quadrivalent Recombinant Influenza Vaccine Versus Egg-Based Inactivated Influenza Vaccine Among Adults Aged 18-64 Years: Results and Experience From a Randomized, Double-Blind Trial.

Issue Release: 2024

Summary of the National Advisory Committee on Immunization (NACI) Supplemental Guidance on Influenza Vaccination in Adults 65 Years of Age and Older.

Issue Release: 2024

Comparative efficacy and safety of vaccines to prevent seasonal influenza: A systematic review and network meta-analysis.

Issue Release: 2022

Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label Trial.

Issue Release: 2022

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season.

Issue Release: 2021

One step closer to influenza vaccine inclusiveness.

Issue Release: 2020

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2019-20 Influenza Season.

Issue Release: 2019

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season.

Issue Release: 2018

Cell culture-derived influenza vaccines in the severe 2017-2018 epidemic season: a step towards improved influenza vaccine effectiveness.

Issue Release: 2018

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season.

Issue Release: 2017

Cost-effectiveness and public health impact of alternative influenza vaccination strategies in high-risk adults.

Issue Release: 2017

Prevention and Control of Seasonal Influenza with Vaccines.

Issue Release: 2016

Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older--United States, 2015.

Issue Release: 2015

Why are Clinical Trials Important?

What Are the Challenges in Vaccine Manufacturing?

What Are the Key Stages in Vaccine Production?

When is Antiviral Therapy Used?

How Do Vaccines Fall Under Biologics?

What Are the Challenges in Implementing Vaccine Training Programs?

What is the MMR Vaccine?

What Should You Do If You Experience Symptoms of a Stroke Post-Vaccination?

What are the Protocols for Safe Vaccine Administration?

What Are the Benefits of Vaccination Programs?

Recombinant Influenza Vaccines (riv) - Vaccines

Relevant Publications

Partnered Content Networks

Relevant Topics